化学名称: 6-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)(3-((1R,2S,3S,4S)-2,3-dihydroxy-4-(2-hydroxyethoxy)cyclopentyl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)amino)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid
微笑: O[C@@H]([C@H]1O)[C@@H](OCCO)C[C@H]1N2N=NC3=C2N=C(SCCC)N=C3N([C@H]4[C@H](C5=CC=C(F)C(F)=C5)C4)C6C(O)C(O)C(O)C(C(O)=O)O6
印地语: InChI=1S/C27H32F2N6O9S/c1-2-5-45-27-30-23(16-24(31-27)35(33-32-16)14-8-15(36)18(38)17(14)37)34(13-7-10(13)9-3-4-11(28)12(29)6-9)25-21(41)19(39)20(40)22(44-25)26(42)43/h3-4,6,10,13-15,17-22,25,36-41H,2,5,7-8H2,1H3,(H,42,43)/t10-,13+,14+,15-,17-,18+,19?,20?,21?,22?,25?/m0/s1
Estimation Of Ticagrelor In Commercial Dosage Form Using A Sensitive Validated RP-HPLC Method
By Madhuri, K.; Rao, Y. Srinivasa; Varaprasada, Rao K.; Deepthi, R.
From World Journal of Pharmaceutical Research (2021), 10(6), 1281-1292.
Development and validation of stability indicating RP-HPLC method for the estimation of Ticagrelor by forced degradation studies
By Dole, Manjusha; Kendre, Meenakshi; Wagh, Viplav
From World Journal of Pharmacy and Pharmaceutical Sciences (2019), 8(5), 711-724
Development of a validated HPLC-PDA method for stability indicating study of ticagrelor: a novel anti-platelet agent (P2Y12-ADP receptor blocker)
By Sulthana, Shabana; Anuradha, V.; Rao, Mandava V. Basaveswara
From International Journal of Pharmaceutical, Chemical and Biological Sciences (2017), 7(1), 36-42